Elevated D-dimers and lack of anticoagulation predict PE in severe COVID-19 patients.
Aged
Anticoagulants
/ administration & dosage
Betacoronavirus
COVID-19
Computed Tomography Angiography
Coronavirus Infections
/ complications
Female
Fibrin Fibrinogen Degradation Products
/ metabolism
France
/ epidemiology
Humans
Male
Oximetry
Pandemics
Pneumonia, Viral
/ complications
Predictive Value of Tests
Pulmonary Embolism
/ diagnostic imaging
Retrospective Studies
SARS-CoV-2
Sensitivity and Specificity
Journal
The European respiratory journal
ISSN: 1399-3003
Titre abrégé: Eur Respir J
Pays: England
ID NLM: 8803460
Informations de publication
Date de publication:
10 2020
10 2020
Historique:
received:
15
05
2020
accepted:
01
07
2020
pubmed:
11
9
2020
medline:
30
10
2020
entrez:
10
9
2020
Statut:
epublish
Résumé
Coronavirus disease 2019 (COVID-19) may predispose to venous thromboembolism. We determined factors independently associated with computed tomography pulmonary angiography (CTPA)-confirmed pulmonary embolism (PE) in hospitalised severe COVID-19 patients. Among all (n=349) patients hospitalised for COVID-19 in a university hospital in a French region with a high rate of COVID-19, we analysed patients who underwent CTPA for clinical signs of severe disease (oxygen saturation measured by pulse oximetry ≤93% or breathing rate ≥30 breaths·min 162 (46.4%) patients underwent CTPA (mean±sd age 65.6±13.0 years; 67.3% male (95% CI 59.5-75.5%). PE was diagnosed in 44 (27.2%) patients. Most PEs were segmental and the rate of PE-related right ventricular dysfunction was 15.9%. By multivariable analysis, the only two significant predictors of CTPA-confirmed PE were D-dimer level and the lack of any anticoagulant therapy (OR 4.0 (95% CI 2.4-6.7) per additional quartile and OR 4.5 (95% CI 1.1-7.4), respectively). Receiver operating characteristic curve analysis identified a D-dimer cut-off value of 2590 ng·mL Elevated D-dimers (>2590 ng·mL
Sections du résumé
BACKGROUND
Coronavirus disease 2019 (COVID-19) may predispose to venous thromboembolism. We determined factors independently associated with computed tomography pulmonary angiography (CTPA)-confirmed pulmonary embolism (PE) in hospitalised severe COVID-19 patients.
METHODS
Among all (n=349) patients hospitalised for COVID-19 in a university hospital in a French region with a high rate of COVID-19, we analysed patients who underwent CTPA for clinical signs of severe disease (oxygen saturation measured by pulse oximetry ≤93% or breathing rate ≥30 breaths·min
RESULTS
162 (46.4%) patients underwent CTPA (mean±sd age 65.6±13.0 years; 67.3% male (95% CI 59.5-75.5%). PE was diagnosed in 44 (27.2%) patients. Most PEs were segmental and the rate of PE-related right ventricular dysfunction was 15.9%. By multivariable analysis, the only two significant predictors of CTPA-confirmed PE were D-dimer level and the lack of any anticoagulant therapy (OR 4.0 (95% CI 2.4-6.7) per additional quartile and OR 4.5 (95% CI 1.1-7.4), respectively). Receiver operating characteristic curve analysis identified a D-dimer cut-off value of 2590 ng·mL
CONCLUSION
Elevated D-dimers (>2590 ng·mL
Identifiants
pubmed: 32907890
pii: 13993003.01811-2020
doi: 10.1183/13993003.01811-2020
pmc: PMC7487272
pii:
doi:
Substances chimiques
Anticoagulants
0
Fibrin Fibrinogen Degradation Products
0
fibrin fragment D
0
Types de publication
Journal Article
Langues
eng
Sous-ensembles de citation
IM
Commentaires et corrections
Type : CommentIn
Type : CommentIn
Informations de copyright
Copyright ©ERS 2020.
Déclaration de conflit d'intérêts
Conflict of interest: B. Mouhat has nothing to disclose. Conflict of interest: M. Besutti has nothing to disclose. Conflict of interest: K. Bouiller has nothing to disclose. Conflict of interest: F. Grillet has nothing to disclose. Conflict of interest: C. Monnin has nothing to disclose. Conflict of interest: F. Ecarnot has nothing to disclose. Conflict of interest: J. Behr has nothing to disclose. Conflict of interest: G. Capellier has nothing to disclose. Conflict of interest: T. Soumagne has nothing to disclose. Conflict of interest: S. Pili-Floury has nothing to disclose. Conflict of interest: G. Besch has nothing to disclose. Conflict of interest: G. Mourey has nothing to disclose. Conflict of interest: Q. Lepiller has nothing to disclose. Conflict of interest: C. Chirouze has nothing to disclose. Conflict of interest: F. Schiele has nothing to disclose. Conflict of interest: R. Chopard has nothing to disclose. Conflict of interest: N. Meneveau has nothing to disclose.
Références
Thromb Haemost. 2020 Jul;120(7):1004-1024
pubmed: 32473596
J Am Coll Cardiol. 2020 Jul 7;76(1):122-124
pubmed: 32387623
JAMA. 2020 Mar 17;323(11):1061-1069
pubmed: 32031570
World J Nephrol. 2017 May 6;6(3):86-99
pubmed: 28540198
Eur Radiol. 2020 Sep;30(9):4903-4909
pubmed: 32314058
Radiology. 2020 Sep;296(3):E189-E191
pubmed: 32324102
Am J Hematol. 2020 Jun;95(6):E131-E134
pubmed: 32129508
Lancet. 2020 Feb 15;395(10223):497-506
pubmed: 31986264
Thromb Res. 2020 Jul;191:145-147
pubmed: 32291094
J Am Coll Cardiol. 2020 Jun 16;75(23):2950-2973
pubmed: 32311448
J Thromb Haemost. 2020 May;18(5):1094-1099
pubmed: 32220112
Epidemiology. 2007 Nov;18(6):800-4
pubmed: 18049194
Circulation. 2020 Jul 14;142(2):184-186
pubmed: 32330083
Lancet. 2020 May 2;395(10234):e75
pubmed: 32330428
Lancet Gastroenterol Hepatol. 2020 May;5(5):428-430
pubmed: 32145190
Thromb Haemost. 2020 May;120(5):876-878
pubmed: 32246450
N Engl J Med. 2020 Apr 30;382(18):1708-1720
pubmed: 32109013
Lancet. 2020 Mar 28;395(10229):1054-1062
pubmed: 32171076
Eur Heart J. 2020 Jan 21;41(4):543-603
pubmed: 31504429
J Thromb Haemost. 2020 Jun;18(6):1421-1424
pubmed: 32271988
J Thromb Haemost. 2020 Jul;18(7):1743-1746
pubmed: 32320517
J Thorac Imaging. 2020 Jul;35(4):219-227
pubmed: 32324653
Thromb Res. 2020 Jul;191:148-150
pubmed: 32381264
J Thromb Haemost. 2020 Apr;18(4):844-847
pubmed: 32073213
Kidney Int. 2020 May;97(5):829-838
pubmed: 32247631
Am J Respir Crit Care Med. 2019 Oct 1;200(7):e45-e67
pubmed: 31573350
Radiology. 2020 Sep;296(3):E186-E188
pubmed: 32324103
JAMA. 2003 Jul 16;290(3):374-80
pubmed: 12865379
Eur Radiol. 2020 Aug;30(8):4407-4416
pubmed: 32215691
N Engl J Med. 2020 Apr 23;382(17):e38
pubmed: 32268022
Radiology. 1992 Nov;185(2):381-7
pubmed: 1410342
Stat Med. 2011 Feb 20;30(4):348-55
pubmed: 21225897
Chest. 2020 Jul;158(1):106-116
pubmed: 32275978